Folgen
-
A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings.
-
Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents.
-
Fehlende Folgen?
-
Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.
-
Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy.
-
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.
-
Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields.
-
Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer.
-
Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.
-
John Field discusses a European position statement on lung cancer screening using low-dose CT.
-
John Field discusses a European position statement on lung cancer screening using low-dose CT.
-
Ben Anderson talks about cancer care and cancer trends in Peru.
-
Ben Anderson talks about cancer care and cancer trends in Peru.
- Mehr anzeigen
